Novartis Ag (NVS) Short-term Investments (2014 - 2025)

Novartis Ag's Short-term Investments history runs 12 years deep, the most recent figure standing at $98.0 million for Q4 2025.

• In Q4 2025, Short-term Investments fell 95.1% year-over-year to $98.0 million; the TTM figure through Dec 2025 stood at $98.0 million (down 95.1% YoY), while the FY2025 annual figure was $98.0 million, down 95.1% from the prior year.
• Short-term Investments came in at $98.0 million for Q4 2025 at Novartis Ag, down from $2.0 billion in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $15.9 billion in Q4 2021 to a low of $98.0 million in Q4 2025.
• A 5-year average of $6.1 billion and a median of $2.0 billion in 2024 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments soared 735.8% in 2021 and tumbled 95.1% in 2025, its largest moves.
• Novartis Ag's Short-term Investments stood at $15.9 billion in 2021, then decreased by 28.32% to $11.4 billion in 2022, then sank by 90.93% to $1.0 billion in 2023, then soared by 93.04% to $2.0 billion in 2024, then sank by 95.1% to $98.0 million in 2025.
• According to Business Quant data, Short-term Investments over the past three periods registered $98.0 million, $2.0 billion, and $1.0 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison